EVP, Global Head of R&D & CMO · Jazz Pharmaceuticals plc · Ordinary Shares
Side
SELL
Value
$76K
Shares
300
Price
$252.76
Executed
Aug 27, 2026
Disclosed
Aug 31, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Aug 27 executedAug 31, 2026 disclosed
JAZZ · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Iannone Robert filed this Form 4 reporting a open-market sale of JAZZ on Aug 27, 2026. It became public on Aug 31, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Global Head of R&D & CMO
Iannone Robertcik:0001737329
Issuer
Jazz Pharmaceuticals plccik:0001232524
Revision history · 0
No field has changed since this record was first ingested.
